Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
pfizer
3
×
san diego blog main
san diego top stories
akcea therapeutics
drugs
fda
inotersen
onpattro
patisiran
san francisco blog main
san francisco top stories
tafamidis
4d molecular therapeutics
abbvie
acne
agenus
alnylam pharmaceuticals
andrew fire
anylam pharmaceuticals
astrazeneca
auris health
avexis
bayer
biomx
biotech
bladder cancer
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of mit and harvard
cancer
What
approved
3
×
drug
fda
alnylam
disease
afternoon
ago
akcea
alnylam’s
amyloidosis
attr
available
battle
bio
companies
debilitating
digital
epidemic
fatty
frenzied
genetic
gets
growing
history
known
landmark
led
liver
making
medicine
medicines
merck
nash
news
ok
oks
onpattro
patients
patisiran
pfizer
Language
Current search:
approved
×
pfizer
×
" clinical trials "
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug